Theratechnologies Net Income From Continuing Ops vs Income Before Tax Analysis

THTX Stock

USD 1.20 0.01 0.83%

Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Net Income From Continuing Ops and its Income Before Tax accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Net Income From Continuing Ops vs Income Before Tax

Net Income From Continuing Ops vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Net Income From Continuing Ops account and Income Before Tax. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Theratechnologies' Net Income From Continuing Ops and Income Before Tax is 0.95. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Net Income From Continuing Ops and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of Theratechnologies are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Net Income From Continuing Ops i.e., Theratechnologies' Net Income From Continuing Ops and Income Before Tax go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Income From Continuing Ops

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Theratechnologies income statement and is an important metric when analyzing Theratechnologies profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Tax Provision is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.34 in 2024, whereas Selling General Administrative is likely to drop slightly above 9.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	80.1M	81.8M	94.0M	98.7M
Depreciation And Amortization	12.0M	3.3M	3.8M	3.1M

Total Revenue Depreciation And Amortization

Theratechnologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Liab	Short Term Investments	Property Plant And Equipment Gross
Total Assets		0.9	0.63	0.06	0.42	0.78	-0.57	0.94	0.68	0.79	-0.18	0.43	0.82	0.79	0.68	0.75	0.67	0.75	0.23	0.84	0.94	0.28	0.84	0.51	0.51	0.3
Short Long Term Debt Total	0.9		0.75	-0.28	0.52	0.83	-0.71	0.8	0.77	0.59	0.13	0.68	0.82	0.81	0.78	0.75	0.55	0.73	0.36	0.91	0.9	0.46	0.66	0.63	0.28	0.44
Total Current Liabilities	0.63	0.75		-0.6	0.58	0.86	-0.71	0.6	0.61	0.31	0.04	0.81	0.66	0.77	0.81	0.35	0.39	0.76	0.56	0.84	0.75	0.81	0.31	0.81	0.29	0.52
Total Stockholder Equity	0.06	-0.28	-0.6		-0.39	-0.46	0.57	0.11	-0.33	0.35	-0.38	-0.81	-0.22	-0.41	-0.58	-0.12	0.19	-0.25	-0.61	-0.44	-0.18	-0.46	0.32	-0.73	0.25	-0.44
Property Plant And Equipment Net	0.42	0.52	0.58	-0.39		0.7	-0.22	0.57	0.29	0.05	0.02	0.49	0.33	0.53	0.5	0.33	0.46	0.67	0.7	0.59	0.5	0.34	0.15	0.52	0.47	0.96
Net Debt	0.78	0.83	0.86	-0.46	0.7		-0.74	0.78	0.59	0.52	-0.08	0.74	0.69	0.87	0.82	0.64	0.64	0.85	0.51	0.92	0.86	0.48	0.53	0.81	0.37	0.56
Retained Earnings	-0.57	-0.71	-0.71	0.57	-0.22	-0.74		-0.4	-0.54	-0.35	-0.03	-0.75	-0.58	-0.65	-0.81	-0.54	-0.38	-0.62	-0.23	-0.74	-0.66	-0.41	-0.26	-0.81	0.07	-0.13
Accounts Payable	0.94	0.8	0.6	0.11	0.57	0.78	-0.4		0.56	0.76	-0.35	0.31	0.69	0.74	0.55	0.66	0.73	0.74	0.31	0.77	0.86	0.26	0.82	0.43	0.55	0.42
Cash	0.68	0.77	0.61	-0.33	0.29	0.59	-0.54	0.56		0.45	0.27	0.76	0.95	0.84	0.78	0.8	0.06	0.46	0.55	0.85	0.83	0.23	0.44	0.67	0.26	0.31
Non Current Assets Total	0.79	0.59	0.31	0.35	0.05	0.52	-0.35	0.76	0.45		-0.27	0.13	0.58	0.56	0.3	0.64	0.6	0.4	-0.19	0.56	0.68	0.07	0.87	0.19	0.36	-0.14
Non Currrent Assets Other	-0.18	0.13	0.04	-0.38	0.02	-0.08	-0.03	-0.35	0.27	-0.27		0.41	0.14	0.04	0.16	0.12	-0.38	-0.17	0.13	0.1	-0.02	0.15	-0.22	0.03	-0.08	0.15
Other Assets	0.43	0.68	0.81	-0.81	0.49	0.74	-0.75	0.31	0.76	0.13	0.41		0.71	0.81	0.89	0.56	0.03	0.53	0.68	0.83	0.67	0.49	0.08	0.91	0.12	0.51
Cash And Short Term Investments	0.82	0.82	0.66	-0.22	0.33	0.69	-0.58	0.69	0.95	0.58	0.14	0.71		0.9	0.84	0.82	0.22	0.6	0.51	0.9	0.93	0.24	0.58	0.7	0.47	0.32
Net Receivables	0.79	0.81	0.77	-0.41	0.53	0.87	-0.65	0.74	0.84	0.56	0.04	0.81	0.9		0.89	0.79	0.29	0.64	0.62	0.95	0.91	0.3	0.57	0.83	0.46	0.47
Common Stock Shares Outstanding	0.68	0.78	0.81	-0.58	0.5	0.82	-0.81	0.55	0.78	0.3	0.16	0.89	0.84	0.89		0.66	0.23	0.71	0.65	0.9	0.84	0.4	0.32	0.91	0.37	0.5
Non Current Liabilities Total	0.75	0.75	0.35	-0.12	0.33	0.64	-0.54	0.66	0.8	0.64	0.12	0.56	0.82	0.79	0.66		0.35	0.5	0.34	0.8	0.82	-0.16	0.63	0.56	0.31	0.26
Inventory	0.67	0.55	0.39	0.19	0.46	0.64	-0.38	0.73	0.06	0.6	-0.38	0.03	0.22	0.29	0.23	0.35		0.77	-0.13	0.45	0.55	0.26	0.6	0.2	0.31	0.25
Other Current Assets	0.75	0.73	0.76	-0.25	0.67	0.85	-0.62	0.74	0.46	0.4	-0.17	0.53	0.6	0.64	0.71	0.5	0.77		0.41	0.77	0.81	0.46	0.42	0.68	0.5	0.57
Other Stockholder Equity	0.23	0.36	0.56	-0.61	0.7	0.51	-0.23	0.31	0.55	-0.19	0.13	0.68	0.51	0.62	0.65	0.34	-0.13	0.41		0.57	0.45	0.23	-0.07	0.68	0.38	0.79
Total Liab	0.84	0.91	0.84	-0.44	0.59	0.92	-0.74	0.77	0.85	0.56	0.1	0.83	0.9	0.95	0.9	0.8	0.45	0.77	0.57		0.96	0.43	0.56	0.84	0.39	0.51
Total Current Assets	0.94	0.9	0.75	-0.18	0.5	0.86	-0.66	0.86	0.83	0.68	-0.02	0.67	0.93	0.91	0.84	0.82	0.55	0.81	0.45	0.96		0.32	0.69	0.72	0.53	0.41
Short Term Debt	0.28	0.46	0.81	-0.46	0.34	0.48	-0.41	0.26	0.23	0.07	0.15	0.49	0.24	0.3	0.4	-0.16	0.26	0.46	0.23	0.43	0.32		0.08	0.38	0.05	0.31
Intangible Assets	0.84	0.66	0.31	0.32	0.15	0.53	-0.26	0.82	0.44	0.87	-0.22	0.08	0.58	0.57	0.32	0.63	0.6	0.42	-0.07	0.56	0.69	0.08		0.12	0.42	-0.01
Other Current Liab	0.51	0.63	0.81	-0.73	0.52	0.81	-0.81	0.43	0.67	0.19	0.03	0.91	0.7	0.83	0.91	0.56	0.2	0.68	0.68	0.84	0.72	0.38	0.12		0.22	0.49
Short Term Investments	0.51	0.28	0.29	0.25	0.47	0.37	0.07	0.55	0.26	0.36	-0.08	0.12	0.47	0.46	0.37	0.31	0.31	0.5	0.38	0.39	0.53	0.05	0.42	0.22		0.48
Property Plant And Equipment Gross	0.3	0.44	0.52	-0.44	0.96	0.56	-0.13	0.42	0.31	-0.14	0.15	0.51	0.32	0.47	0.5	0.26	0.25	0.57	0.79	0.51	0.41	0.31	-0.01	0.49	0.48

Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	100.1M	119.2M	93.3M	77.8M	89.4M	65.2M
Short Long Term Debt Total	55.4M	56.7M	66.7M	59.0M	67.8M	37.4M
Total Current Liabilities	41.9M	45.1M	114.3M	47.3M	54.4M	57.1M
Total Stockholder Equity	3.2M	17.8M	(22.6M)	(20.9M)	(18.8M)	(17.8M)
Property Plant And Equipment Net	3.5M	2.9M	3.1M	2.0M	1.8M	1.3M
Net Debt	42.6M	36.3M	42.9M	24.9M	28.6M	30.0M
Retained Earnings	(300.1M)	(335.2M)	(382.6M)	(408.7M)	(367.8M)	(349.4M)
Accounts Payable	17.5M	15.5M	12.9M	7.0M	8.0M	6.4M
Cash	12.7M	20.4M	23.9M	34.1M	39.2M	41.2M
Non Current Assets Total	35.3M	27.3M	19.9M	14.5M	16.6M	29.9M
Non Currrent Assets Other	(35.3M)	(26.7M)	(18.1M)	467K	420.3K	399.3K
Cash And Short Term Investments	20.8M	40.4M	33.1M	40.9M	47.0M	49.3M
Net Receivables	13.2M	10.9M	12.3M	12.8M	14.7M	15.5M
Common Stock Shares Outstanding	19.2M	23.1M	23.8M	26.3M	23.7M	23.5M
Liabilities And Stockholders Equity	100.1M	119.2M	93.3M	77.8M	89.4M	62.7M
Non Current Liabilities Total	55.0M	56.4M	1.6M	51.3M	59.0M	62.0M
Inventory	25.1M	29.1M	19.7M	6.1M	7.0M	7.8M
Other Current Assets	5.7M	13.2M	10.0M	4.0M	4.7M	4.9M
Other Stockholder Equity	12.1M	12.8M	20.9M	23.2M	20.9M	19.8M
Total Liab	96.9M	101.5M	115.8M	98.6M	113.4M	119.1M
Total Current Assets	64.8M	91.9M	73.4M	63.3M	72.8M	76.4M
Short Term Debt	1.1M	463K	65.3M	7.7M	8.9M	9.2M
Intangible Assets	31.9M	23.8M	15.0M	12.5M	14.4M	13.2M
Other Current Liab	23.2M	29.0M	35.7M	32.6M	37.5M	39.4M
Short Term Investments	8.0M	20.0M	9.2M	6.8M	6.1M	9.6M
Accumulated Other Comprehensive Income	(481K)	(44K)	385K	684.0K	786.6K	430.9K
Property Plant And Equipment Gross	3.5M	3.6M	3.9M	3.2M	2.9M	1.5M
Current Deferred Revenue	70K	50K	54K	38K	34.2K	32.5K
Common Stock	287.3M	335.8M	338.8M	363.9M	418.5M	306.7M
Net Tangible Assets	(14.9M)	(28.6M)	(6.1M)	(37.6M)	(33.8M)	(32.1M)
Long Term Debt	50.7M	52.4M	54.2M	50.7M	58.3M	38.2M
Property Plant Equipment	1.1M	3.5M	2.9M	3.1M	3.6M	3.7M
Net Invested Capital	55.6M	72.0M	42.2M	37.1M	33.4M	45.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theratechnologies Net Income From Continuing Ops vs Income Before Tax Analysis

Net Income From Continuing Ops vs Income Before Tax

Net Income From Continuing Ops vs Income Before Tax Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Income Before Tax

Theratechnologies fundamental ratios Correlations

Theratechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theratechnologies fundamental ratios Accounts

Also Currently Popular

Additional Tools for Theratechnologies Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 0.96	Property Plant And Equipment Net
Total Current Assets	+ 0.96	Total Liab
Cash And Short Term Investments	+ 0.95	Cash
Total Liab	+ 0.95	Net Receivables
Accounts Payable	+ 0.94	Total Assets
Total Current Assets	+ 0.94	Total Assets

Other Current Liab	- 0.81	Retained Earnings
Common Stock Shares Outstanding	- 0.81	Retained Earnings
Other Assets	- 0.81	Total Stockholder Equity
Other Assets	- 0.75	Retained Earnings
Total Liab	- 0.74	Retained Earnings
Retained Earnings	- 0.74	Net Debt